Addition of Dose-Intensified Doxorubicin to Standard Chemotherapy for Rhabdomyosarcoma (epssg RMS 2005): a Multicentre, Open-Label, Randomised Controlled, Phase 3 Trial.Gianni Bisogno,Meriel Jenney,Christophe Bergeron,Soledad Gallego Melcon,Andrea Ferrari,Odile Oberlin,Modesto Carli,Michael Stevens,Anna Kelsey,Angela De Paoli,Mark N. Gaze,Helene Martelli,Christine Devalck,Johannes H. Merks,Myriam Ben-Arush,Heidi Glosli,Julia Chisholm,Daniel Orbach,Veronique Minard-Colin,Gian Luca De SalvoLancet oncology/Lancet Oncology（2018）引用 141|浏览60暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
